Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective

Name: Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective
SKU: 3076
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 3 Articles Tags: abrupt-switch, clozapine, crossover, medworks-media, michael-w-jann, olanzapine, pharmacodynamics, pharmacokinetics, psychopharmacology-bulletin, richard-m-bunt, switching-antipsychotics, ziprasidone

Description

Description

Michael W. Jann, PharmD, FCCP, BCPP

DRUG DISPOSITIONS AND PHARMACOKINETICS

Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective

switching antipsychotics, pharmacokinetics, pharmacodynamics, crossover, abrupt switch, clozapine, olanzapine, ziprasidone

Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective

Description

Michael W. Jann, PharmD, FCCP, BCPP

Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality

Clozapine Factors in Schizophrenia by Takefumi Suzuki

Assessment of Anxiety in Clinical Trials with Depressed Patients

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective

Description

Michael W. Jann, PharmD, FCCP, BCPP

Related products

Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality

Clozapine Factors in Schizophrenia by Takefumi Suzuki

Assessment of Anxiety in Clinical Trials with Depressed Patients

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki